IN2014DN09392A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN09392A IN2014DN09392A IN9392DEN2014A IN2014DN09392A IN 2014DN09392 A IN2014DN09392 A IN 2014DN09392A IN 9392DEN2014 A IN9392DEN2014 A IN 9392DEN2014A IN 2014DN09392 A IN2014DN09392 A IN 2014DN09392A
- Authority
- IN
- India
- Prior art keywords
- compounds
- essentially pure
- xxv
- stimulating
- formulas
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000000356 contaminant Substances 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H13/06—Fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261623393P | 2012-04-12 | 2012-04-12 | |
| US13/842,424 US9241988B2 (en) | 2012-04-12 | 2013-03-15 | Disaccharide synthetic lipid compounds and uses thereof |
| PCT/US2013/036425 WO2013155448A1 (en) | 2012-04-12 | 2013-04-12 | Disaccharide synthetic lipid compounds and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN09392A true IN2014DN09392A (enExample) | 2015-07-17 |
Family
ID=49325307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN9392DEN2014 IN2014DN09392A (enExample) | 2012-04-12 | 2013-04-12 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US9241988B2 (enExample) |
| EP (2) | EP3674309B1 (enExample) |
| JP (3) | JP6271510B2 (enExample) |
| CN (2) | CN107412766A (enExample) |
| CA (1) | CA2870008C (enExample) |
| DK (1) | DK3674309T3 (enExample) |
| ES (2) | ES2992314T3 (enExample) |
| IN (1) | IN2014DN09392A (enExample) |
| WO (1) | WO2013155448A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2468300B1 (en) | 2006-09-26 | 2017-12-20 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
| US9241988B2 (en) * | 2012-04-12 | 2016-01-26 | Avanti Polar Lipids, Inc. | Disaccharide synthetic lipid compounds and uses thereof |
| SMT201800368T1 (it) | 2012-05-16 | 2018-09-13 | Immune Design Corp | Vaccini per l'infezione da virus-2 herpes simplex |
| US9504743B2 (en) | 2013-09-25 | 2016-11-29 | Sequoia Sciences, Inc | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| US20150086592A1 (en) | 2013-09-25 | 2015-03-26 | Sequoia Sciences, Inc | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| US9149521B2 (en) | 2013-09-25 | 2015-10-06 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| US9149522B2 (en) | 2013-09-25 | 2015-10-06 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| CN107073105B (zh) * | 2014-09-12 | 2021-04-06 | 巴斯特威尔控股有限公司 | 用于提供含佐剂病毒体的方法及由此可获得的含佐剂病毒体 |
| CN107405395A (zh) * | 2015-03-17 | 2017-11-28 | 红杉科学有限公司 | 疫苗与佐剂的组合物以及治疗尿路感染的方法 |
| EP3069729A1 (en) * | 2015-03-17 | 2016-09-21 | Sequoia Sciences, Inc. | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections |
| WO2020055503A1 (en) | 2018-09-14 | 2020-03-19 | Massachusetts Institute Of Technology | Nanoparticle vaccine adjuvant and methods of use thereof |
| CA3118692A1 (en) | 2018-11-06 | 2020-05-14 | Alsatech, Inc. | Cell-based gene therapy for neurodegenerative diseases |
| EP3886901A1 (en) * | 2018-11-29 | 2021-10-06 | GlaxoSmithKline Biologicals S.A. | Methods for manufacturing an adjuvant |
| BR112022008761A2 (pt) | 2019-11-22 | 2022-07-26 | Glaxosmithkline Biologicals Sa | Dosagem e administração de uma vacina de glicoconjugado de sacarídeo |
| WO2023114570A1 (en) | 2021-12-19 | 2023-06-22 | Massachusetts Institute Of Technology | Compositions and methods for long-lasting germinal center responses to a priming immunization |
| WO2024064783A1 (en) | 2022-09-21 | 2024-03-28 | Wisconsin Alumni Research Foundation | Compositions and methods to enhance therapeutic efficacy of cancer therapies |
| WO2024151642A1 (en) * | 2023-01-09 | 2024-07-18 | University Of Maryland, Baltimore | Engineered anti-nociceptive-los competitive tlr4 ligands and methods for treating pain while maintaining immunosufficiency |
| WO2026087792A1 (en) | 2024-10-27 | 2026-04-30 | Idorsia Pharmaceuticals Ltd | Vaccine against klebsiella pneumoniae |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5066794A (en) | 1984-08-24 | 1991-11-19 | Daiichi Pharmaceutical Co., Ltd. | Process for preparing a disaccharide derivative |
| GR860379B (en) * | 1985-02-22 | 1986-06-11 | Akzo Nv | Novel disaccharide and trisaccharide derivatives of the lipid a type |
| JP2535048B2 (ja) | 1988-02-29 | 1996-09-18 | 第一製薬株式会社 | 新規ジサッカライド誘導体及びその塩 |
| JPH06206893A (ja) * | 1992-09-07 | 1994-07-26 | Suntory Ltd | 新規なジサッカライド誘導体 |
| WO1995007285A1 (en) | 1993-09-07 | 1995-03-16 | Suntory Limited | Novel disaccharide derivative |
| PT729473E (pt) | 1993-11-17 | 2001-02-28 | Deutsche Om Arzneimittel Gmbh | Dissacaridos de glucosamina metodo para a sua preparacao composicao farmaceutica contendo os mesmos e sua utilizacao |
| JPH10152497A (ja) * | 1996-09-30 | 1998-06-09 | Otsuka Pharmaceut Factory Inc | ヘリコバクター・ピロリのリピドａ |
| CA2330610A1 (en) * | 1998-05-07 | 1999-11-11 | Corixa Corporation | Adjuvant composition and methods for its use |
| CA2333578C (en) | 1998-07-14 | 2010-11-16 | American Cyanamid Company | Adjuvant and vaccine compositions containing monophosphoryl lipid a |
| US20020022032A1 (en) * | 1999-04-23 | 2002-02-21 | Curry Patrick Mark | Immuno-adjuvant PDT treatment of metastatic tumors |
| US7491707B1 (en) | 1999-11-15 | 2009-02-17 | Biomira, Inc. | Synthetic lipid-a-analogs and uses thereof |
| PT1284740E (pt) * | 2000-05-19 | 2008-07-09 | Corixa Corp | Tratamento profiláctico e terapêutico de doenças infecciosas, autoimunes e alérgicas com compostos à base de monossacáridos |
| CN1907289A (zh) * | 2000-05-19 | 2007-02-07 | 科里克萨有限公司 | 用单糖和二糖类化合物预防和治疗传染病和其他疾病的方法 |
| US20030031684A1 (en) * | 2001-03-30 | 2003-02-13 | Corixa Corporation | Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid a (3D-MLA) |
| GB0420634D0 (en) * | 2004-09-16 | 2004-10-20 | Glaxosmithkline Biolog Sa | Vaccines |
| US7622128B2 (en) * | 2005-12-13 | 2009-11-24 | University Of Washington | Porphyromonas gingivalis 1435/1449 LPS as an immune modulator |
| WO2008059307A2 (en) | 2006-11-16 | 2008-05-22 | Om Pharma | Functionalized beta 1,6 glucosamine disaccharides and process for their preparation |
| US8563523B2 (en) | 2007-09-07 | 2013-10-22 | University Of Georgia Research Foundation, Inc. | Synthetic lipid A derivative |
| US8563002B2 (en) * | 2007-12-24 | 2013-10-22 | Glaxosmithkline Biologicals, S.A. | Recombinant RSV antigens |
| US9241988B2 (en) * | 2012-04-12 | 2016-01-26 | Avanti Polar Lipids, Inc. | Disaccharide synthetic lipid compounds and uses thereof |
-
2013
- 2013-03-15 US US13/842,424 patent/US9241988B2/en active Active
- 2013-04-12 WO PCT/US2013/036425 patent/WO2013155448A1/en not_active Ceased
- 2013-04-12 IN IN9392DEN2014 patent/IN2014DN09392A/en unknown
- 2013-04-12 DK DK20157427.4T patent/DK3674309T3/da active
- 2013-04-12 EP EP20157427.4A patent/EP3674309B1/en active Active
- 2013-04-12 ES ES20157427T patent/ES2992314T3/es active Active
- 2013-04-12 ES ES13775926T patent/ES2787876T3/es active Active
- 2013-04-12 JP JP2015505953A patent/JP6271510B2/ja active Active
- 2013-04-12 CA CA2870008A patent/CA2870008C/en active Active
- 2013-04-12 CN CN201710534045.0A patent/CN107412766A/zh active Pending
- 2013-04-12 EP EP13775926.2A patent/EP2836499B1/en active Active
- 2013-04-12 CN CN201380026285.XA patent/CN104470938B/zh active Active
-
2016
- 2016-01-26 US US15/006,938 patent/US10143744B2/en active Active
-
2017
- 2017-12-26 JP JP2017248795A patent/JP6764396B2/ja active Active
-
2020
- 2020-05-26 JP JP2020091157A patent/JP7189906B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018070652A (ja) | 2018-05-10 |
| JP6764396B2 (ja) | 2020-09-30 |
| HK1207383A1 (en) | 2016-01-29 |
| EP3674309A1 (en) | 2020-07-01 |
| CN104470938B (zh) | 2017-07-28 |
| US10143744B2 (en) | 2018-12-04 |
| CN104470938A (zh) | 2015-03-25 |
| JP2015512946A (ja) | 2015-04-30 |
| US9241988B2 (en) | 2016-01-26 |
| EP3674309B1 (en) | 2024-09-11 |
| EP2836499A1 (en) | 2015-02-18 |
| JP6271510B2 (ja) | 2018-01-31 |
| CA2870008A1 (en) | 2013-10-17 |
| ES2787876T3 (es) | 2020-10-19 |
| DK3674309T3 (da) | 2024-11-25 |
| CN107412766A (zh) | 2017-12-01 |
| CA2870008C (en) | 2021-05-04 |
| JP2020147579A (ja) | 2020-09-17 |
| EP2836499B1 (en) | 2020-02-26 |
| ES2992314T3 (es) | 2024-12-11 |
| JP7189906B2 (ja) | 2022-12-14 |
| EP2836499A4 (en) | 2015-11-25 |
| US20130273149A1 (en) | 2013-10-17 |
| US20160136271A1 (en) | 2016-05-19 |
| WO2013155448A1 (en) | 2013-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2015287674B2 (en) | Topical antiviral compositions and methods of using the same | |
| PH12016501151A1 (en) | Nrf2 regulators | |
| PH12015502401A1 (en) | Compositions and methods for enhancing microbial stability | |
| MX2016011898A (es) | Composiciones de compuestos selenoorganicos y metodos de uso de los mismos. | |
| PH12015502216A1 (en) | Compositions and methods for improving the health of aquatic animals | |
| EP3679785A3 (en) | Methods and compositions for integration of an exogenous sequence within the genome of plants | |
| PH12014502350A1 (en) | Mixtures, methods and compositions pertaining to conductive materials | |
| EA201290876A1 (ru) | Композиции индуцированных дендритных клеток и их использование | |
| GB0917002D0 (en) | Improved shigella blebs | |
| EP3725811A3 (en) | Compositions for inhibiting masp-2 dependent complement activation | |
| MX360499B (es) | Cepas microbianas, composiciones y metodos para incrementar el fosfato disponible para las plantas. | |
| EP4480544A3 (en) | Immunomodulatory compositions andmethods of use thereof | |
| MX2021004211A (es) | Composiciones vacuna. | |
| MX2011014019A (es) | Derivados de diazahomoadamantano y sus metodos de uso. | |
| IN2014DN06104A (enExample) | ||
| MX348325B (es) | Composicion que contiene galacto-oligosacarido y un metodo para producirla. | |
| MY190647A (en) | Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof | |
| PH12017500836A1 (en) | Transdermal formulations | |
| MX2018011162A (es) | Metodos de purificacion de colageno 7. | |
| MX2016000313A (es) | Estabilizadores de luz novedosos. | |
| SG10201900541QA (en) | Derivatives of xanthone compounds | |
| IN2014DN03298A (enExample) | ||
| IN2014DN08412A (enExample) | ||
| IN2013MU03641A (enExample) | ||
| SG10201805890QA (en) | Compositions and methods for treatment of abnormal cell growth |